Identified a specific eight-amino acid region in the VP1 protein as a major target for type 3 poliovirus neutralization, which is likely necessary for vaccine development.
Answers are grounded in this paper and cite their sources.
May inform type 3 poliovirus vaccine design; leaves open human validation and clinical translation.
Antigenic mutants of type 3 poliovirus were obtained by picking plaques formed in the presence of neutralizing monoclonal antibodies. All the mutants were clustered into a single operationally defined antigenic site based on their reactions with a panel of antibodies. Most of the mutations were shown to be located in the virion protein VP1 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and oligonucleotide mapping, and 15 of 16 mutants had single-point mutations in a region of VP1 encompassing only eight amino acids, a finding suggesting that this is a major target for the neutralization of the virus. Whereas other areas may also be required, it is likely that this region is a necessary component of a vaccine of any kind.
No takes yet. Share an insight, caveat, or question.
Minor et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: